Latest News about biotech
Recent news which mentions biotech
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
From Benzinga
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
February 16, 2024
From Benzinga
Why Is Gilead Sciences Stock Trading Lower Today?
February 16, 2024
From Benzinga
Why Is Liver Disease-Focused Inventiva Stock Trading Lower Today?
February 16, 2024
From Benzinga
What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday?
February 16, 2024
From Benzinga
Why Is Alnylam Pharmaceuticals Stock Trading Lower On Thursday?
February 15, 2024
From Benzinga
From Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
February 15, 2024
From Benzinga
Pfizer's Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call - Main Takeaways
February 15, 2024
From Benzinga
UK Becomes First Major Market for Eli Lilly's Mounjaro Prefilled Pen For Tackling Obesity
February 15, 2024
From Benzinga
Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback
February 15, 2024
From Benzinga
What's Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk's Weight Loss Drug Wegovy
February 15, 2024
From Benzinga
From Benzinga
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion Piece
February 14, 2024
From Benzinga
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
February 14, 2024
From Benzinga
What's Going On With Eli Lilly Stock Wednesday?
February 14, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.